Publications found:
677
Sort by:
Chronic Lymphocytic Leukemia Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Aggressive CLL, Indolent CLL, Others), By Treatment (Targeted Drug Therapy, Chemotherapy, Bone Marrow Transplant, Immunotherapy), By Route of Administration (Oral, Parental, Others), By End user (Hospital, Diagnostic Laboratories, Research Institutes, Others), By Region and Competition, 2020-2030F
US$ 4,500.00
The Global Chronic Lymphocytic Leukemia Treatment Market will grow from USD 13.37 Billion in 2024 to USD 21.51 Billion by 2030 at a 8.25% CAGR. The global chronic lymphocytic leukemia (CLL) treatment...
December 2025
185 pages
Melanoma Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Therapy (Chemotherapy, Immunotherapy, Targeted Therapy), By Disease Type (Superficial Spreading Melanoma, Lentigo Maligna, Acral Lentiginous Melanoma, Nodular Melanoma), By Application (Hospitals, Outpatient Oncologist Clinics, Others), By Region and Competition, 2020-2030F
US$ 4,500.00
The Global Melanoma Drugs Market will grow from USD 7.42 Billion in 2024 to USD 11.98 Billion by 2030 at a 8.31% CAGR. Melanoma drugs refer to pharmaceutical agents developed to treat melanoma, an agg...
December 2025
185 pages
Myeloproliferative Disorders Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Primary Myelofibrosis, Polycythemia Vera, Essential Thrombocythemia, Hyper eosinophilic Syndrome, Systemic Masto cytosis), By Drug Type (JAK2 Inhibitors, Anti-Neoplastic, Demethylation Agents, Imatinib Mesylate, Others), By Route of Administration (Oral, Parental, Others), By Distribution Channel (Hospital Pharmacy, Retail Stores, Drug Stores), By Region and Competition, 2020-2030F
US$ 4,500.00
The Global Myeloproliferative Disorders Drugs Market will grow from USD 9.94 Billion in 2024 to USD 14.06 Billion by 2030 at a 5.95% CAGR. Myeloproliferative Disorders (MPDs) drugs comprise a speciali...
December 2025
185 pages
Tyrosine Kinase Inhibitors Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (BCR-ABL Tyrosine Kinase Inhibitor, Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors, Vascular Endothelial Growth Factor Receptor (VEGFR) Tyrosine Kinase Inhibitors, Other), By Application (Chronic Myeloid Leukemia (CML), Lung Cancer, Breast Cancer, Renal Cell Cancer, Other), By Region, By Competition, 2020-2030F
US$ 4,500.00
The Global Tyrosine Kinase Inhibitors Market will grow from USD 52.07 Billion in 2024 to USD 83.09 Billion by 2030 at a 8.10% CAGR. Tyrosine Kinase Inhibitors, or TKIs, are a class of pharmaceutical d...
December 2025
183 pages
Angiosarcoma Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Hemangiosarcoma, Lymphangiosarcoma, Parenchymal Angiosarcoma), By Treatment (Surgery, Radiotherapy, Chemotherapy, Targeted Therapy, Immunotherapy, Others), By End user (Hospital & Clinics, Ambulatory Surgical Centers, Online Pharmacies), By Region and Competition, 2020-2030F
US$ 4,500.00
The Global Angiosarcoma Treatment Market , valued at USD 280.11 Million in 2024, is projected to experience a CAGR of 6.11% to reach USD 399.85 Million by 2030. Angiosarcoma treatment encompasses a ra...
December 2025
180 pages
Precision Oncology Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product Type (Diagnostics, Therapeutics), By Cancer Type (Breast Cancer, Cervical Cancer, Prostate Cancer, Lung Cancer), By End User (Hospitals & Diagnostic Laboratories, Pharmaceutical & Biotechnology Companies, Healthcare Data Companies) Region and Competition, 2020-2030F
US$ 4,500.00
The Global Precision Oncology Market , valued at USD 99.45 Billion in 2024, is projected to experience a CAGR of 9.12% to reach USD 167.87 Billion by 2030. Precision oncology tailors cancer treatment...
December 2025
183 pages
Acute Myeloid Leukemia Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Chemotherapy (Cytarabine, Anthracycline Drugs, Alkylating Agents, Anti-metabolites, Tyrosine Kinase Inhibitors, hormonal therapy, and other chemotherapies), By Region, and Competition, 2020-2030F
US$ 4,500.00
The Global Acute Myeloid Leukemia Market, valued at USD 1.56 Billion in 2024, is projected to experience a CAGR of 8.90% to reach USD 2.63 Billion by 2030. Acute Myeloid Leukemia (AML) is a rapidly pr...
December 2025
183 pages
Breast Cancer Drugs Market Size, Share & Trends Analysis Report By Therapy (Hormonal Therapy, Targeted Therapy, Chemotherapy, Immunotherapy), By Cancer Type, By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2033
US$ 5,950.00
The global breast cancer drugs market size was estimated at USD 36.62 billion in 2024 and is projected to reach USD 69.72 billion by 2033, growing at a CAGR of 7.09% from 2025 to 2033. The market is...
December 2025
150 pages
Non-Hodgkin Lymphoma Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Disease Type (B-cell Lymphomas, T-cell Lymphoma), By Drug Class (Monoclonal Antibodies, Antibody-Drug Conjugates, BTK/BCL-2 Kinase Inhibitors, PI3 Kinase Inhibitors, Others), By Route of Administration (Oral, Parenteral, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Other Distribution Channels), By Region and Competition, 2020-2030F
US$ 4,500.00
The Global Non-Hodgkin Lymphoma Market, valued at USD 7.24 Billion in 2024, is projected to experience a CAGR of 7.72% to reach USD 11.31 Billion by 2030. The global Non-Hodgkin Lymphoma market compri...
November 2025
187 pages
Anticancer Drug Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Indication (Breast Cancer, Blood Cancer, Prostate Cancer, Gastrointestinal Cancer, Gynecologic Cancer, Lung Cancer, Others), By Drug (Cytotoxic, Hormonal Therapy, Targeted Therapy, Others), By Route of Administration (Oral, Parenteral, Others), By End User (Hospitals & Clinics, Ambulatory Care Centers, Others), By Region and Competition, 2020-2030F
US$ 4,500.00
The Global Anticancer Drug Market, valued at USD 179.93 Billion in 2024, is projected to experience a CAGR of 5.25% to reach USD 244.59 Billion by 2030. Anticancer drugs represent pharmaceutical agent...
November 2025
185 pages
Non-Hodgkin Lymphoma (NHL) Therapeutics Market By Type of Therapy (Immunotherapy, Targeted Therapy, Chemotherapy, Stem Cell Transplant, Others), By Cell Type (B-cell Lymphomas, T-cell Lymphomas), By Drug Type (Revlimid, Rituxan, Keytruda, Imbruvica, Opdivo, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others), By Region, Competition Forecast & Opportunities, 2020-2030F
US$ 4,500.00
The Global Non-Hodgkin Lymphoma (NHL) Therapeutics Market , valued at USD 8.19 Billion in 2024, is projected to experience a CAGR of 7.61% to reach USD 12.72 Billion by 2030. Non-Hodgkin Lymphoma (NHL...
November 2025
180 pages
Oncology Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Drug Class (Cytotoxic Drugs, Targeted Drugs, Hormonal Drugs, Others), By Route of Administration (Oral, Parenteral, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Others), By Region and Competition, 2020-2030F
US$ 4,500.00
The Global Oncology Drugs Market, valued at USD 228.65 Billion in 2024, is projected to experience a CAGR of 13.33% to reach USD 484.54 Billion by 2030. Oncology drugs are pharmaceutical agents develo...
November 2025
185 pages
Cancer Drugs Market Outlook 2026-2034: Market Share, and Growth Analysis By Type (Chemotherapy, Targeted Therapy, Immunotherapy, Hormonal Therapy, Others), By Application (Blood Cancer, Breast Cancer, Gastrointestinal Cancer, Prostate Cancer, Respiratory/Lung Cancer, Others)
US$ 3,950.00
The Cancer Drugs Market is valued at USD 267 billion in 2025 and is projected to grow at a CAGR of 14.3% to reach USD 889.1 billion by 2034. Cancer Drugs Market The Cancer Drugs Market encompasses tar...
November 2025
160 pages
CAR T cell Therapy Market Outlook 2026-2034: Market Share, and Growth Analysis By Product (Abecma (idecabtagene vicleucel), Breyanzi (lisocabtagene maraleucel), Carvykti (ciltacabtagene autoleucel), Kymriah (tisagenlecleucel), Tecartus (brexucabtagene autoleucel), Yescarta (axicabtagene ciloleucel), Others), By Disease Indication (Leukemia, Lymphoma, Multiple Myeloma, Others), By End-User
US$ 3,950.00
The CAR T cell Therapy Market is valued at USD 5.72 billion in 2025 and is projected to grow at a CAGR of 28% to reach USD 52.76 billion by 2034. CAR T cell Therapy Market CAR?T cell therapy refers to...
November 2025
160 pages
Keytruda Market Outlook 2026-2034: Market Share, and Growth Analysis By Application (Lung Cancer, Breast Cancer, Melanoma, Hodgkin Lymphoma, Head and Neck Cancer, Gastric Cancer, Urothelial Cancer, Others), By Payer (Commercial/Private, Public), By Distribution Channel
US$ 3,950.00
The Keytruda Market is valued at USD 29.87 billion in 2025 and is projected to grow at a CAGR of 9% to reach USD 64.87 billion by 2034. Keytruda Market Keytruda (pembrolizumab) has evolved into a corn...
November 2025
160 pages
Testicular Cancer Drugs Market Size, Share & Trends Analysis Report By Drug Class (Platinum Compounds, Alkylating Agents), By Disease Type (Seminoma, Non-Seminomatous Germ Cell Tumors), By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2033
US$ 5,950.00
The global testicular cancer drugs market size was estimated at USD 1.08 billion in 2024 and is projected to reach USD 1.97 billion by 2033, growing at a CAGR of 6.9% from 2025 to 2033. The market is...
November 2025
150 pages
Cancer Cachexia Market Size, Share & Trends Analysis Report By Treatment (Appetite Stimulants, Corticosteroids), By Type (Lung Cancer, Colorectal Cancer), By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2033
US$ 5,950.00
The global cancer cachexia market size was estimated at USD 2.54 billion in 2024 and is projected to reach USD 3.90 billion by 2033, growing at a CAGR of 4.86% from 2025 to 2033. The rising cancer inc...
November 2025
150 pages
Bevacizumab Biosimilars Market Outlook 2025-2034: Market Share, and Growth Analysis By Product (Avastin, Mvasi, Zirabev, Aybintio, Other Products), By Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy, Other Distribution Channels), By Application
US$ 3,950.00
The Bevacizumab Biosimilars Market is valued at USD 2.1 billion in 2025 and is projected to grow at a CAGR of 8.3% to reach USD 4.3 billion by 2034.The bevacizumab biosimilars market is rapidly growin...
October 2025
160 pages
Checkpoint Inhibitors Market Outlook 2025-2034: Market Share, and Growth Analysis By Drug (PD-1 Inhibitors, PD-L1 Inhibitors, CTLA-4, Chimeric Antigen Receptor T-cell, Other Drugs), By Application (Lung Cancer, Renal Cancer, Blood Cancer, Bladder Cancer, Melanoma, Other Applications), By End-Users
US$ 3,950.00
The Checkpoint Inhibitors Market is valued at USD 36.8 billion in 2025 and is projected to grow at a CAGR of 19.1% to reach USD 177.4 billion by 2034. The checkpoint inhibitors market has emerged as a...
October 2025
160 pages
Chemotherapy-Induced Nausea And Vomiting (Cinv) Market Outlook 2025-2034: Market Share, and Growth Analysis By Form (Injectables, Oral, Transdermal Patches), By Drug Class (5-HT3 Receptor Antagonists, Neurokinin-1 Receptor Antagonists, Corticosteroids, Cannabinoids, Other Drug Class), By Emetogenic Risk, By Distribution Channel, By Application
US$ 3,950.00
The Chemotherapy-Induced Nausea And Vomiting (Cinv) Market is valued at USD 3.7 billion in 2025 and is projected to grow at a CAGR of 7.9% to reach USD 7.3 billion by 2034.The Chemotherapy-Induced Nau...
October 2025
160 pages
Chronic Myeloid Leukemia (Cml) Treatment Market Outlook 2025-2034: Market Share, and Growth Analysis By Type (Targeted Therapy, Chemotherapy, Radiation Therapy, Splenectomy, Stem Cell Transplant), By Drug Type (Tyrosine Kinase Inhibitors, Antimetabolites, Other Drug Types), By Application, By Distribution Channel
US$ 3,950.00
The Chronic Myeloid Leukemia (Cml) Treatment Market is valued at USD 10.7 billion in 2025 and is projected to grow at a CAGR of 5.5% to reach USD 17.3 billion by 2034.The chronic myeloid leukemia (CML...
October 2025
160 pages
Endometrial Cancer Treatment Market Outlook 2025-2034: Market Share, and Growth Analysis By Type (Adenocarcinoma, Uterine Carcinosarcoma, Squamous Cell Carcinoma, Small Cell Carcinoma, Transitional Carcinoma, Serous Carcinoma, Other Types), By Diagnosis Method (Biopsy, Pelvic Ultrasound, Hysteroscopy, CT Scan, Other Diagnosis Methods), By Route Of Administration, By Distribution Channel
US$ 3,950.00
The Endometrial Cancer Treatment Market is valued at USD 27.7 billion in 2025 and is projected to grow at a CAGR of 4.8% to reach USD 42.1 billion by 2034. Market Overview: Endometrial Cancer Treatmen...
October 2025
160 pages
Poly Adp-Ribose Polymerase (Parp) Inhibitor Market Outlook 2025-2034: Market Share, and Growth Analysis By Drug Type (Talazoparib, Veliparib, Olaparib, Other Drug Types), By Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy, Other Distribution Channels), By Application, By End Users
US$ 3,950.00
The Poly Adp-Ribose Polymerase (Parp) Inhibitor Market is valued at USD 8.8 billion in 2025 and is projected to grow at a CAGR of 10.8% to reach USD 22.1 billion by 2034. Poly ADP-Ribose Polymerase (P...
October 2025
160 pages
Proteasome Inhibitors Market Outlook 2025-2034: Market Share, and Growth Analysis By Product (Velcade, Kyprolis, Ninlaro, Other Products), By Drugs (Bortezomib, Carfilzomib, Ixazomib), By Indication, By Distribution Channel, By End-User
US$ 3,950.00
The Proteasome Inhibitors Market is valued at USD 2.6 billion in 2025 and is projected to grow at a CAGR of 8.8% to reach USD 5.6 billion by 2034. Proteasome Inhibitors Market Overview The proteasome...
October 2025
160 pages
Acute Myeloid Leukemia Market Outlook 2025-2034: Market Share, and Growth Analysis By Treatment Type (Chemotherapy, Radiation therapy, Stem Cell Transplant, Targeted Therapy), By Chemotherapy (Cytarabine, Anthracycline Drugs, Alkylating Agents, Anti-metabolites, Tyrosine Kinase Inhibitors, Hormonal Therapy), By Regimen, By End-User
US$ 3,950.00
The Acute Myeloid Leukemia Market is valued at USD 3.1 billion in 2025 and is projected to grow at a CAGR of 9.1% to reach USD 6.8 billion by 2034.The acute myeloid leukemia (AML) market is a speciali...
October 2025
160 pages
Anthracycline Market Outlook 2025-2034: Market Share, and Growth Analysis By Drugs (Daunorubicin, Doxorubicin, Epirubicin, Idarubicin, Mitoxantrone, Valrubicin), By Dosage (Powder, Capsule, Solution, Injection, Suspension, Other Dosages), By Application, By End User
US$ 3,950.00
The Anthracycline Market is valued at USD 2 billion in 2025 and is projected to grow at a CAGR of 8.4% to reach USD 4.1 billion by 2034. Anthracycline Market The Anthracycline Market is expanding nota...
October 2025
160 pages
Anti-Cancer Mabs Market Outlook 2025-2034: Market Share, and Growth Analysis By Type (Murine Antibodies, Chimeric Antibodies, Humanized Antibodies, Other Types), By Application (Blood Cancer, Breast Cancer, Lung Cancer, Melanoma, Colorectal Cancer, Liver Cancer, Other Applications), By End User
US$ 3,950.00
The Anti-Cancer Mabs Market is valued at USD 62.6 billion in 2025 and is projected to grow at a CAGR of 8.8% to reach USD 133.4 billion by 2034.The Anti-Cancer Monoclonal Antibodies (MAbS) Market is a...
October 2025
160 pages
Anti-Neoplastic Agents Market Outlook 2025-2034: Market Share, and Growth Analysis By Type (Alkylating Agents, Antimetabolites, Hormones And Antagonists, Miscellaneous), By Disease Type (Gastrointestinal Cancer, Prostate Cancer, Lung Cancer, Breast Cancer, Other Disease Types), By End User
US$ 3,950.00
The Anti-Neoplastic Agents Market is valued at USD 127.3 billion in 2025 and is projected to grow at a CAGR of 9.4% to reach USD 285.5 billion by 2034.The Anti-Neoplastic Agents Market focuses on the...
October 2025
160 pages
Blood Cancer Drugs Market Outlook 2025-2034: Market Share, and Growth Analysis By Blood Cancer Type (Leukemia, Lymphoma), By Drugs (Rituxan/Mabthera (Rituximab), Gleevec/Glivec (Imatinib), Revlimid (Lenalidomide), Velcade (Bortezomib), Tasigna (Nilotinib), Pomalyst (Pomalidomide), Vidaza (Azacitidine), Kyprolis (Carfilzomib), Adcetris (Brentuximab Vedotin), Other Drugs), By Treatment Approaches
US$ 3,950.00
The Blood Cancer Drugs Market is valued at USD 67.1 billion in 2025 and is projected to grow at a CAGR of 8.4% to reach USD 138.9 billion by 2034.The Blood Cancer Drugs Market is experiencing substant...
October 2025
160 pages
Breast Cancer Drugs Market Outlook 2025-2034: Market Share, and Growth Analysis By Type (Metastatic Breast Cancer, Triple Negative Breast Cancer, Others (Ductal Carcinoma Insitu, Invasive Ductal Carcinoma, Inflammatory Breast Cancer, Breast Cancer During Pregnancy, Others)), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies/ Drug Stores, Other Distribution Channels), By End User
US$ 3,950.00
The Breast Cancer Drugs Market is valued at USD 38.8 billion in 2025 and is projected to grow at a CAGR of 8.3% to reach USD 79.3 billion by 2034.The breast cancer drugs market represents one of the m...
October 2025
160 pages
Cancer Monoclonal Antibodies Market Outlook 2025-2034: Market Share, and Growth Analysis By Monoclonal Antibody Therapies (Avastin, Herceptin, Keytruda, Opdivo, Darzalex, Perjeta, Others), By Application (Breast Cancer, Blood Cancer, Lung Cancer, Brain Tumor, Colorectal Cancer, Cervical Cancer, Gastric Cancer, Others), By End-User
US$ 3,950.00
The Cancer Monoclonal Antibodies Market is valued at USD 61.2 billion in 2025 and is projected to grow at a CAGR of 10.4% to reach USD 149.1 billion by 2034. Cancer Monoclonal Antibodies Market The ca...
October 2025
160 pages
